Literature DB >> 32281216

Comparison of the transcriptional profile in the decidua of early-onset and late-onset pre-eclampsia.

Jing Tong1,2, Yichao Niu1,2, Zi-Jiang Chen1,2, Cong Zhang1,2,3.   

Abstract

AIM: To compare early-onset pre-eclampsia (EOPE) and late-onset pre-eclampsia (LOPE) and provide insight into the pathophysiology of pre-eclampsia (PE).
METHODS: Our recent work compared the transcriptomics in decidua of EOPE, LOPE and normal pregnancies (NP).
RESULTS: We found there are a significant number of genes uniquely expressed in the decidua of EOPE and LOPE comparing with NP. Moreover, EOPE and LOPE have their distinct profiles. Unique EOPE-associated genes were mainly involved in apoptosis related pathways such as 'apoptosis' and 'Ras signaling pathway'. PIK3CB and BCL-2 are the core regulatory genes in EOPE decidua, their abnormal expression caused decidual abnormal apoptosis which is relevant to the pathogenesis of EOPE. Whereas, LOPE is a more complicated entity which has more special LOPE-associated genes involved in decidua differentiation, especially in 'gap junction pathway', 'vascular smooth muscle contraction' and 'long-term depression'. PIK3CB, FLT1, CBLC and ITGA7 are the core regulatory genes differentially expressed in EOPE decidua comparing with LOPE.
CONCLUSION: In brief, the different decidual transcriptomics of EOPE and LOPE may correlate with their different etiology. These findings highlight the complex pathophysiology of PE and provide potential targets for a new treatment strategy in patients with PE.
© 2020 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  RNA-seq; decidua; early-onset pre-eclampsia; late-onset pre-eclampsia; transcriptomics

Mesh:

Year:  2020        PMID: 32281216     DOI: 10.1111/jog.14257

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  6 in total

1.  Low-dose aspirin inhibits trophoblast cell apoptosis by activating the CREB/Bcl-2 pathway in pre-eclampsia.

Authors:  Kai-Min Guo; Wei Li; Zhao-Hua Wang; Lang-Chi He; Yan Feng; Hui-Shu Liu
Journal:  Cell Cycle       Date:  2022-07-06       Impact factor: 5.173

2.  Effect of human follicle-stimulating hormone on immunomodulatory function of decidual mesenchymal stem cells by reducing interleukin-6 levels.

Authors:  Yi-Bo He; Li Zhang; Lin-Li Zhou; Yi-Min Chen; Jia-Hong Lu; Jie Chen; Yong-Lin Liu
Journal:  J Ovarian Res       Date:  2022-05-13       Impact factor: 5.506

3.  Dysfunction of Decidual Macrophages Is a Potential Risk Factor in the Occurrence of Preeclampsia.

Authors:  Miaomiao Rong; Xingyu Yan; Hongya Zhang; Chan Zhou; Cong Zhang
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

4.  The Impact of PTPRK and ROS1 Polymorphisms on the Preeclampsia Risk in Han Chinese Women.

Authors:  Huihui Li; Xingyu Yan; Man Yang; Mei Liu; Shan Tian; Mengru Yu; Wei-Ping Li; Cong Zhang
Journal:  Int J Hypertens       Date:  2021-10-04       Impact factor: 2.420

5.  Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction.

Authors:  Siv Boon Mundal; Johanne Johnsen Rakner; Gabriela Brettas Silva; Lobke Marijn Gierman; Marie Austdal; Purusotam Basnet; Mattijs Elschot; Siril Skaret Bakke; Jenny Ostrop; Liv Cecilie Vestrheim Thomsen; Eric Keith Moses; Ganesh Acharya; Line Bjørge; Ann-Charlotte Iversen
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

6.  Gene Expression Network Analysis Identifies Potential Targets for Prevention of Preeclampsia.

Authors:  Yu Xia; Yu-Dong Zhao; Gui-Xiang Sun; Shuai-Shuai Xia; Zheng-Wang Yang
Journal:  Int J Gen Med       Date:  2022-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.